«Sankyo Company Limited

Below is an extended Sankyo Company Limited news listing. Click here to return to the Sankyo Company Limited main Biocorporate entry.

BioNews Results for Sankyo Company Limited:
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Quamnet: Aug 31 2008 11:23PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared KLFY: Aug 31 2008 1:44PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Nashville Business Journal: Aug 31 2008 1:42PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Business Journal of Milwaukee: Aug 31 2008 1:41PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Cincinnati Business Journal: Aug 31 2008 1:36PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Columbus Business First: Aug 31 2008 1:32PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Portland Business Journal: Aug 31 2008 1:32PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared San Antonio Business Journal: Aug 31 2008 1:28PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared The Business Journal Phoenix: Aug 31 2008 1:28PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Atlanta Business Chronicle: Aug 31 2008 1:27PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared San Francisco Business Times: Aug 31 2008 1:26PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared Forbes.com: Aug 31 2008 1:37PM Matching: sankyo company
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared PR Newswire via Yahoo!: Aug 31 2008 1:28PM Matching: sankyo company
Eli Lily Says Antiplatelet Drug Prasugrel Reduces Cardiac Risks In Diabetes Patient By 30% - Update Quote.com United States: Aug 31 2008 4:55PM Matching: sankyo company
Eli Lily Says Antiplatelet Drug Prasugrel Reduces Cardiac Risks In Diabetes Patient By 30% - Update RTTNews.com: Aug 31 2008 2:28PM Matching: sankyo company

«Sankyo Company Limited

This page contained an extended Sankyo Company Limited news listing. Click here to return to the Sankyo Company Limited main Biocorporate entry.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.